Meta-QSAR: a large-scale application of meta-learning to drug design and discovery
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0565
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Meta-QSAR: a large-scale application of meta-learning to drug design and discovery ; volume:107 ; number:1 ; day:22 ; month:12 ; year:2017 ; pages:285-311 ; date:1.2018
Machine learning ; 107, Heft 1 (22.12.2017), 285-311, 1.2018
- Urheber
-
Olier, Ivan
- Beteiligte Personen und Organisationen
-
Sadawi, Noureddin
Bickerton, G. Richard
Vanschoren, Joaquin
Grosan, Crina
Soldatova, Larisa
King, Ross D.
SpringerLink (Online service)
- DOI
-
10.1007/s10994-017-5685-x
- URN
-
urn:nbn:de:1111-201802268118
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Olier, Ivan
- Sadawi, Noureddin
- Bickerton, G. Richard
- Vanschoren, Joaquin
- Grosan, Crina
- Soldatova, Larisa
- King, Ross D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
QSAR of anti-inflammatory drugs
MetaEuk—sensitive, high-throughput gene discovery, and annotation for large-scale eukaryotic metagenomics
QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach
Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery
Molecular quantum similarity in QSAR and drug design
Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery
Epigenetic drug discovery
Successful Drug Discovery
Large-scale analysis of kinase inhibitors' target binding kinetics : implications for drug discovery?
Large-scale analysis of kinase inhibitors' target binding kinetics : implications for drug discovery?
Reply to “Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery”
Rethinking 3D-QSAR
QSAR of anti-inflammatory drugs
MetaEuk—sensitive, high-throughput gene discovery, and annotation for large-scale eukaryotic metagenomics
QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach
Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery
Molecular quantum similarity in QSAR and drug design
Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery
Epigenetic drug discovery
Successful Drug Discovery
Large-scale analysis of kinase inhibitors' target binding kinetics : implications for drug discovery?
Large-scale analysis of kinase inhibitors' target binding kinetics : implications for drug discovery?
Reply to “Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery”
Rethinking 3D-QSAR
QSAR of anti-inflammatory drugs
MetaEuk—sensitive, high-throughput gene discovery, and annotation for large-scale eukaryotic metagenomics
QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach
Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery
Molecular quantum similarity in QSAR and drug design
Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery
Epigenetic drug discovery
Successful Drug Discovery
Large-scale analysis of kinase inhibitors' target binding kinetics : implications for drug discovery?
Large-scale analysis of kinase inhibitors' target binding kinetics : implications for drug discovery?
Reply to “Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery”